Today, we’re introducing GPT‑Rosalind, our frontier reasoning model built to support research across biology, drug discovery, and translational medicine.cientists must work across large volumes of literature, specialized databases, experimental data, and evolving hypotheses in order to generate and evaluate new ideas. These workflows are often time-intensive, fragmented, and difficult to scale.

We believe advanced AI systems can help researchers move through these workflows faster—not just by making existing work more efficient, but by helping scientists explore more possibilities, surface connections that might otherwise be missed, and arrive at better hypotheses sooner. By supporting evidence synthesis, hypothesis generation, experimental planning, and other multi-step research tasks, this model is designed to help researchers accelerate the early stages of discovery.